Literature DB >> 3125218

High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.

D F Sahm1, C Torres.   

Abstract

We investigated the use of high-content aminoglycoside disks for determining Enterococcus faecalis susceptibility to aminoglycoside-penicillin synergy. The susceptibility of the organisms to synergy was established by 24-h time-kill studies performed with streptomycin, kanamycin, amikacin, gentamicin, and tobramycin, alone and in combination with penicillin. A total of 20 isolates that were susceptible to all drug combinations and 20 strains that were resistant to each aminoglycoside-penicillin combination were selected for testing against high-content disks. Disk-agar diffusion was performed on Mueller-Hinton agar, with and without 5% sheep blood, by using disks that contained either 300 or 2,000 micrograms of streptomycin and either 120 or 2,000 micrograms of kanamycin, amikacin, tobramycin, or gentamicin. Zone size results obtained for each aminoglycoside, except amikacin, could be used to differentiate between synergy-susceptible and -resistant isolates. No overlap occurred between the zone sizes of susceptible and resistant strains. Susceptibility to amikacin-penicillin synergy could reliably be tested with kanamycin, but not amikacin, disks. When the disks containing 120 micrograms were tested, a narrow zone size range of 6 to 7 mm could be used to identify all resistant strains. In contrast, when the disks containing 2,000 micrograms were used, the zone size ranges for resistant isolates varied widely with the aminoglycoside being tested. The presence of blood in the medium did not appreciably affect the disk test results. To detect resistance to every aminoglycoside-penicillin combination that may be considered for therapy, E. faecalis isolates need to be tested against a maximum of three different high-content disks (i.e., streptomycin, gentamicin, kanamycin). The disk-agar diffusion test performed with high-content aminoglycoside disks can provide laboratories with a convenient and reliable method for detecting E. faecalis isolates that are resistant to aminoglycoside-penicillin synergy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125218      PMCID: PMC266262          DOI: 10.1128/jcm.26.2.257-260.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.

Authors:  S A Calderwood; C Wennersten; R C Moellering; L J Kunz; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

2.  Synergy of penicillin and gentamicin against Enterococci.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

3.  An aminoglycoside disk sensitivity test for use with enterococci.

Authors:  S L Rosenthal; L F Freundlich
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

4.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

5.  Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci.

Authors:  P Courvalin; C Carlier; E Collatz
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

6.  Aminoglycoside-resistant enterococci.

Authors:  M J Basker; B Slocombe; R Sutherland
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

7.  Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.

Authors:  R C Moellering; C Wennersten; A J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

8.  High-level resistance to gentamicin in clinical isolates of enterococci.

Authors:  B D Mederski-Samoraj; B E Murray
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

9.  Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis.

Authors:  D F Sahm; C Torres
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

10.  Medium-dependent activity of gentamicin sulfate against enterococci.

Authors:  E A Raymond; W H Traub
Journal:  Appl Microbiol       Date:  1971-02
View more
  26 in total

1.  From vanA Enterococcus hirae to vanA Enterococcus faecium: a study of feed supplementation with avoparcin and tylosin in young chickens.

Authors:  B Robredo; K V Singh; F Baquero; B E Murray; C Torres
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

3.  Comparison of the new MicroScan Pos MIC Type 6 panel and AMS-Vitek Gram Positive Susceptibility Card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species.

Authors:  S Szeto; M Louie; D E Low; M Patel; A E Simor
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

4.  The rapid emergence of high level gentamicin resistance in enterococci.

Authors:  K R Forward; J K Kennedy; P A Degagne; K R Bartlett; G K Harding
Journal:  Can J Infect Dis       Date:  1990

5.  Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; P C Iwen; J L Baade; G L Woods
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

6.  Comparison of four methods for testing high-level aminoglycoside resistance in enterococci.

Authors:  P Yagupsky; S Petry; M A Menegus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

7.  Evaluation of a commercial microtiter system (MicroScan) using both frozen and freeze-dried panels for detection of high-level aminoglycoside resistance in Enterococcus spp.

Authors:  S A Fuller; D E Low; A E Simor
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

8.  Neonatal bacteremia due to high level aminoglycoside resistant (HLAR) enterococci.

Authors:  K G Bhat; C Paul; M G Bhat
Journal:  Indian J Pediatr       Date:  1997 Jul-Aug       Impact factor: 1.967

9.  In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

Authors:  D F Sahm; J Kissinger; M S Gilmore; P R Murray; R Mulder; J Solliday; B Clarke
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

10.  Gentamicin-resistant enterococci and endocarditis.

Authors:  R Holliman; E Smyth
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.